Alcon recall
February 27th 2008
   |
|
Alcon recall
US FDA/CDRH: Class I Recall: Alcon Refractive Horizons, Inc ...
Class I Medical Device Recalls - Alcon Refractive Horizons, Inc. LADAR6000™ Excimer Laser System (more...)
OnlineBusinessBureau.com Protecting Consumers.
Over one million businesses and websites rated for consumers to investigate. Buyer beware! ... Alcon Announces Voluntary Recall of Systane Free LIQUID GEL Lubricant Eye Drops [04 ... (more...)
Alcon Issues Voluntary Recall of Systane(r) Gel Lubricant Eye Drops ...
Alcon issues Recall of Systane Free Liquid Gel Lubricant Eye Drops ... Alcon Announces Voluntary Recall of Systane(r) Free LIQUID GEL Lubricant Eye Drops (more...)
Alcon Recall LADAR6000 Excimer Laser Eye Surgery System
Claim compensation if you have been affected by this product ... Alcon Recall LADAR6000 Excimer Laser Eye Surgery System. LADAR6000 Excimer Laser Eye Surgery System recall (more...)
Alcon: Information from Answers.com
In December 2006, Alcon announced a voluntary recall of Systane® Free LIQUID GEL lubricant eyedrops due to problems with possible contamination of the drops after opening. (more...)
Accurate Optical
Alcon Announces Voluntary Recall of Systaneﾮ Free LIQUID GEL Lubricant Eye Drops in the U.S. 15 Dec, 2006 Alcon Laboratories, Inc., a subsidiary of Alcon, Inc. (NYSE: (more...)
FDA Recalls Alcon Lasik Laser
Reports of serious Lasik complications lead to recall of all Alcon LADARVision 6000 laser units worldwide. (more...)
FDA > CDRH > Recall Database Search
Z-0560-2007 - Alcon Custom-Pak®, part #10975-02, containing BD Beaver® Mini-Blade (part #BD6400 or part #BD6900); individual blades repackaged into custom ophthalmic surgical ... (more...)
Alcon Announces Voluntary Recall of Systane® Free LIQUID GEL ...
Alcon Laboratories, Inc., a subsidiary of Alcon, Inc. (NYSE: ACL), announced today a voluntary recall of Systane® Free LIQUID GEL lubricant eye drops. (more...)
Alcon Inc. (ACL)
Alcon, Inc. (ACL) is one of the world's leading suppliers of eye care products. ... The consumer eye care segment continued to benefit from the recall of two competitive ... (more...)